To hear about similar clinical trials, please enter your email below

Trial Title: Single-center Ambispective Observational Study on the Role of Magnetic Resonance Imaging (MRI) in the Evaluation of Patient Affected by Hepatic Metastases of Carcinoma of the Colorectal Cancer (CRC).

NCT ID: NCT05950503

Condition: Colorectal Cancer

Conditions: Official terms:
Colorectal Neoplasms

Study type: Observational

Overall status: Recruiting

Study design:

Time perspective: Prospective

Intervention:

Intervention type: Radiation
Intervention name: Hepatic MRI
Description: The patients will undergo hepatic MRI in pre-established timepoints
Arm group label: mCRC patients

Summary: This study wants to evaluate the use of MRI in the managemente of mCRC with liver only metastases.

Criteria for eligibility:

Study pop:
Colorectal cancer patients with liver metastases treated at the U.O.C. of Medical Oncology of Foundation Agostino Gemelli University Hospital

Sampling method: Non-Probability Sample
Criteria:
Inclusion Criteria: - Age > 18 years; - Histological diagnosis of colorectal cancer; - Presence of liver metastases in the staging exams (chest-abdomen CT with contrast medium or PET-CT with 18-FDG); - At least one measurable liver lesion according to RECIST 1.1 criteria; - Adequate organ and marrow function. Exclusion Criteria: - Age < 18 years; - Inability to undergo MRI; - Major contraindications to liver surgery; - No written informed consent.

Gender: All

Minimum age: 18 Years

Maximum age: 85 Years

Locations:

Facility:
Name: Policlinico Agostino Gemelli

Address:
City: Roma
Country: Italy

Status: Recruiting

Contact:
Last name: Lisa Salvatore, MD, PhD

Phone: 0630156318
Email: lisa.salvatore@policlinicogemelli.it

Start date: July 10, 2023

Completion date: June 7, 2027

Lead sponsor:
Agency: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Agency class: Other

Source: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05950503

Login to your account

Did you forget your password?